Success Metrics

Clinical Success Rate
75.0%

Based on 6 completed trials

Completion Rate
75%(6/8)
Active Trials
2(12%)
Results Posted
33%(2 trials)
Terminated
2(12%)

Phase Distribution

Ph not_applicable
7
41%
Ph phase_1
2
12%
Ph phase_2
1
6%
Ph phase_4
1
6%
Ph phase_3
1
6%
Ph early_phase_1
1
6%

Phase Distribution

3

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution13 total trials
Early Phase 1First-in-human
1(7.7%)
Phase 1Safety & dosage
2(15.4%)
Phase 2Efficacy & side effects
1(7.7%)
Phase 3Large-scale testing
1(7.7%)
Phase 4Post-market surveillance
1(7.7%)
N/ANon-phased studies
7(53.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

54.5%

6 of 11 finished

Non-Completion Rate

45.5%

5 ended early

Currently Active

2

trials recruiting

Total Trials

17

all time

Status Distribution
Active(2)
Completed(6)
Terminated(5)
Other(4)

Detailed Status

Completed6
unknown4
Withdrawn3
Recruiting2
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
17
Active
2
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (7.7%)
Phase 12 (15.4%)
Phase 21 (7.7%)
Phase 31 (7.7%)
Phase 41 (7.7%)
N/A7 (53.8%)

Trials by Status

recruiting212%
completed635%
terminated212%
unknown424%
withdrawn318%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials
NCT04522219Phase 3

Contribution of Contrast Enhanced Ultrasound in the Diagnosis of Adnexal Torsion

Terminated
NCT04721886Early Phase 1

Contrast-Enhanced Ultrasound Scan for the Estimation of Tissue Pressure in Patients With Breast Cancer

Completed
NCT07335315

Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors

Recruiting
NCT07054229

Efficacy and Prognosis of Microwave Ablation Treatment for Papillary Thyroid Microcarcinoma Assessed by Contrast-Enhanced Ultrasound Combined With Genetic and Molecular Diagnostics: A Prospective Observational Study

Recruiting
NCT05977777Not Applicable

Contrast-enhanced Ultrasound and Pancreatic Lesions

Unknown
NCT03458975Phase 2

Targeted Delivery of Chemotherapy With Ultrasound and Microbublles

Completed
NCT04615559Not Applicable

Contrast Enhanced Ultrasound Endoleak Identification and Classification

Withdrawn
NCT02277977Not Applicable

Evaluation of Impaired Microcirculation During Septic Shock With Contrast Enhanced Ultrasound

Withdrawn
NCT02688751

Contrast Enhanced Ultrasound, Endoleak Detection Following EVAR v1.3

Completed
NCT04847726Not Applicable

Contrast-enhanced Ultrasound With Perfluorobutane and Sulfur Hexafluoride for Hepatocellular Carcinoma

Completed
NCT04181281

Validation of Renal Perfusion CEUS Against MRI, and Its Application in Acute Kidney Injury

Unknown
NCT04660136Phase 4

Usefulness of Contrast-enhanced Ultrasound (CEUS) in Crohn's Disease Pediatric Patients

Unknown
NCT02086331Not Applicable

Evaluation of Musculoskeletal Microcirculation With Ultrasound

Terminated
NCT04494022Not Applicable

Role of CEUS as a Secondary Diagnostic Modality

Unknown
NCT01763840Phase 1

Contrast Enhanced Ultrasound for Evaluation of Pediatric Abdominal Trauma

Completed
NCT02061163Phase 1

Contrast-Enhanced Ultrasound in Human Crohn's Disease

Withdrawn
NCT01522209Not Applicable

Detection Rate of Liver Metastases With Contrast Enhanced Intraoperative Ultrasound Compared to Regular Imaging

Completed

All 17 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
17